Central Nervous System Agents in Medicinal Chemistry
Title:Acknowledgements to Reviewers
Volume: 18 Issue: 3
Author(s):
Affiliation:
Export Options
About this article
Cite this article as:
, Acknowledgements to Reviewers, Central Nervous System Agents in Medicinal Chemistry 2018; 18 (3) . https://dx.doi.org/10.2174/187152491803181001155943
DOI https://dx.doi.org/10.2174/187152491803181001155943 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |
18
2
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pharmacogenomics of Arylamine N-acetyltransferase
Current Pharmacogenomics Involvement of Lanthanides in the Free Radicals Homeostasis
Current Topics in Medicinal Chemistry How to Review the Medication History to Find the Next Best Drug: The “Pretreatment-Next Treatment Algorithm and Checklist”
Current Psychopharmacology Monoamine Involvement in the Antidepressant-Like Effect of β-Caryophyllene
CNS & Neurological Disorders - Drug Targets Role of Environmental Factors in Cocaine Addiction
Current Pharmaceutical Design Neurotoxicity: The Broad Framework of Electron Transfer, Oxidative Stress and Protection by Antioxidants
Current Medicinal Chemistry - Central Nervous System Agents Developing Pharmacotherapies for Cannabis and Cocaine Use Disorders
Current Neuropharmacology Editorial
Current Topics in Medicinal Chemistry Hydrazonoyl Halides as Precursors for Synthesis of Bioactive Thiazole and Thiadiazole Derivatives: Synthesis, Molecular Docking and Pharmacological Study
Current Organic Synthesis Alteration of the Beta-Adrenergic Signaling Pathway in Human Heart Failure
Current Pharmaceutical Biotechnology Immunity to Tuberculosis and Novel Therapeutic Strategies
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Inhibition of Neurogenesis by Zika Virus Infection
CNS & Neurological Disorders - Drug Targets Neuroinflammation: Microglial Activation During Sepsis
Current Neurovascular Research Development of Timolol Maleate Loaded Chitosan Nanoparticles For Improved Ocular Delivery
Pharmaceutical Nanotechnology Use of Nanoparticles as Therapy for Methicillin-Resistant Staphylococcus aureus Infections
Current Drug Metabolism Structure and Function of Myelinated Nerve Fibers in the Rabbit Eye Following Ischemia/Reperfusion Injury
Current Neurovascular Research Cyclodextrins in Nitrosation Chemistry: New Insights of the NO-Transfer Processes
Mini-Reviews in Organic Chemistry Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets Dietary Intake and Bone Status with Aging
Current Pharmaceutical Design Expression of Specificity Protein Transcription Factors in Pancreatic Cancer and their Association in Prognosis and Therapy
Current Medicinal Chemistry